P2'-modified hydroxamic acid collagenase inhibitors

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

562451, 562623, C07C22934, C07C25906

Patent

active

053006747

ABSTRACT:
Compounds of general formula I: ##STR1## Wherein: R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are variables.
These compounds have collagenase inhibition activity and are useful in the management of disease involving collagen degradation. Its uses include rheumatoide arthritis, corneal ulceration, osteoporosis, periodontitis, gingivitis and tumour invasion.

REFERENCES:
patent: 4105789 (1978-08-01), Ondetti et al.
patent: 4496540 (1985-01-01), Kim
patent: 4599361 (1986-07-01), Dickens et al.
Woolley et al., Arthritis and Rheumatism 20 pp. 1231-1239 (1977).
Evans, et al., J. Am. Chem. Soc. 104: pp. 1737-1739 (1982).
Cawston and Barrett, Anal. Biochem. 99: pp. 340-345 (1979).
Cawston and Murphy, Methods in Enzymology 80: pp. 711-722 (1981).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

P2'-modified hydroxamic acid collagenase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with P2'-modified hydroxamic acid collagenase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and P2'-modified hydroxamic acid collagenase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-512616

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.